Mountain Crest Acquisition CORP V Form 4 insider transactions

Mountain Crest Acquisition Corp. V's CEO and 10% owner, Suying Liu, reported the disposition of 200,000 common shares at $5 per share, contingent on the company's initial business combination.

Mountain Crest Global Holdings LLC reported the sale of 200,000 shares of Mountain Crest Acquisition Corp. V common stock at $5 per share, with transfer contingent on a business combination.

Suying Liu, CEO and CFO of Mountain Crest Acquisition Corp. V, sold 100,000 shares of common stock on February 17, 2025, at $7 per share.

Mountain Crest Global Holdings LLC, a 10% owner of Mountain Crest Acquisition Corp. V, sold 100,000 shares of common stock on February 17, 2025.

CUBEBIO, a Korean in-vitro diagnostic company, plans to go public on Nasdaq through a business combination with Mountain Crest Acquisition Corp. V, valuing CUBEBIO at $375 million.

Suying Liu, CEO and CFO of Mountain Crest Acquisition Corp. V, reports acquiring beneficial ownership of 2,165,800 shares of common stock and rights to purchase common stock through Mountain Crest Global Holdings LLC.

Dong Liu, previously a manager at Mountain Crest Global Holdings LLC, no longer has voting or dispositive control over shares held by the entity as of July 8, 2024.

Mountain Crest Acquisition Corp. V and CUBEBIO Co., Ltd. have entered into a non-binding term sheet for a proposed business combination that would result in CUBEBIO becoming a publicly listed company on The Nasdaq Stock Market.

Mountain Crest Global Holdings LLC, a 10% owner and entity related to director Dong Liu, converted $600,000 of promissory notes into 150,000 shares of common stock at $4.00 per share.